Skip to main
AZTA

Azenta (AZTA) Stock Forecast & Price Target

Azenta (AZTA) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 40%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Azenta is a well-established life sciences company that operates in multiple global markets, with a diverse portfolio including cutting-edge sample management solutions and genomic analysis services. Despite missing consensus in FQ26, the company has taken a conservative approach in its lowered guidance and balance sheet and strong FCF profile provides protection from further downside. Additionally, potential drivers such as faster outsourcing and stronger earnings growth support a positive outlook for Azenta's stock.

Bears say

Azenta is a company that provides sample exploration and management solutions using automation and cryogenics. Despite a weak market demand for automated and cryo stores, the company's revenue and EPS have missed consensus and their growth has slowed. The company has lowered its revenue growth guidance and extended its LRP, which indicates a negative outlook for its future performance. The bull case scenario predicts higher growth and margin improvement, while the bear case scenario assumes flat or negative revenue growth. The base case calls for moderate growth and improved margins, and the company's potential upside drivers include increased outsourcing and accretive M&A.

Azenta (AZTA) has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 40% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Azenta and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Azenta (AZTA) Forecast

Analysts have given Azenta (AZTA) a Buy based on their latest research and market trends.

According to 5 analysts, Azenta (AZTA) has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $38.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $38.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Azenta (AZTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.